Cell & Gene Therapy

colorful brain art model
Biotech

Astellas pays Sangamo $20M to boost neurological gene therapies

Astellas continues to strengthen its neurological gene therapy capabilities, handing Sangamo $20 million upfront to bypass the blood-brain barrier.
James Waldron Dec 19, 2024 7:13am
Black phone dangling by cord in phonebooth

Ring lays off nearly half of staff, CEO to exit in new year

Dec 18, 2024 2:31pm
eye eyeball eye art

Aurion's regenerative med improves vision in phase 1/2 trial

Dec 18, 2024 7:00am
Helophilia

Roche culls ph. 3 Spark gene therapy in hemophilia

Dec 16, 2024 12:24pm
peeling an orange

Bristol Myers culls cell therapy deals with 2 biotechs

Dec 16, 2024 11:19am
A series of dice with a bag on them illustrating cost cuts

Editas lays off 65% after fruitless search for reni-cel partner

Dec 13, 2024 4:44am
More News

Gene therapy reduces seizures in mice with severe epilepsy

Dec 9, 2024 11:46am

Carisma axes sole clinical candidate, lays off 34% of staff

Dec 9, 2024 10:58am

Protara shares spike after bladder cancer data drop

Dec 5, 2024 2:30pm

Cash-strapped Medigene lays off 40%, pauses plan to enter clinic

Nov 26, 2024 6:52am